Genetic code for prostate cancer unravelled

10 February 2011

Scientists have unravelled the genetic code for prostate cancer and believe the breakthrough could herald a number of new cancer diagnosis and treatment options for patients.

The deciphering of the genetic material has been lauded as a breakthrough in cancer research and offers clinicians a picture of the fundamental causes of the disease.

In the future, it is hoped that the understanding of the genetics behind cancer will allow for far more personalised treatment.

Dr Michael Berger, a scientist working at the Massachusetts Institute of Technology and Harvard, in the US, sequenced the genomes of seven different variants of prostate cancer.

"This is a transforming moment in understanding the underlying biology of prostate cancer," the researcher said.

He added: "It offers the potential of new targets for treatment and earlier diagnosis of the more aggressive strains of the disease."

In the UK, around 37,000 men are diagnosed with prostate cancer every year.


1 Berger, Dr Michael. "The genomic complexity of primary human prostate cancer". Nature. Thursday, February 10th 2011.

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cancer

© Spire Healthcare Group plc (2016)